AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$376M |
| 2 |
Honeywell
HON
|
+$325M |
| 3 |
Progressive
PGR
|
+$288M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$232M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLL
L3 Technologies, Inc.
LLL
|
+$529M |
| 2 |
RTX Corp
RTX
|
+$496M |
| 3 |
CVS Health
CVS
|
+$406M |
| 4 |
US Bancorp
USB
|
+$395M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$279M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.51% |
| 2 | Technology | 14.95% |
| 3 | Healthcare | 13.16% |
| 4 | Industrials | 10.42% |
| 5 | Consumer Discretionary | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
PUT
iShares Russell 2000 ETF
IWM
$79.8B
| $41.5M | 0.03% |
307,500
+194,600
| +172% | +$24.9M |
|
502
APA Corp
APA
$13.2B
| $41.4M | 0.03% |
652,704
-18,522
| -3% | -$1.17M |
|
503
NOV
NOV
$6.93B
| $41.1M | 0.03% |
1,097,458
-59,177
| -5% | -$2.16M |
|
|
PPL
504
PPL Corp
PPL
$26.5B
| $41M | 0.03% |
1,203,046
-4,233,418
| -78% | -$142M |
|
|
INFN
505
DELISTED
Infinera Corporation Common Stock
INFN
| $40.8M | 0.03% |
4,803,803
+508,609
| +12% | +$4.36M |
|
506
United Airlines
UAL
$39.4B
| $40.7M | 0.03% |
559,073
-20,602
| -4% | -$1.31M |
|
507
Criteo S.A. Ordinary Shares
CRTO
$1.1B
| $40.7M | 0.03% |
990,175
+467,749
| +90% | +$18.2M |
|
|
PFPT
508
DELISTED
Proofpoint, Inc.
PFPT
| $40.6M | 0.03% |
575,194
+16,114
| +3% | +$1.21M |
|
509
Prothena Corp
PRTA
$425M
| $40.5M | 0.03% |
823,315
+42,672
| +5% | +$2.35M |
|
|
CBPO
510
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $40.3M | 0.03% |
374,555
+160,458
| +75% | +$18.8M |
|
511
Healthpeak Properties
DOC
$15.1B
| $40.2M | 0.03% |
1,351,060
-192,574
| -12% | -$5.87M |
|
|
STJ
512
DELISTED
St Jude Medical
STJ
| $40.1M | 0.03% |
500,633
+4,040
| +0.8% | +$321K |
|
|
TSS
513
DELISTED
Total System Services, Inc.
TSS
| $39.9M | 0.03% |
814,299
+45,865
| +6% | +$2.25M |
|
514
Neurocrine Biosciences
NBIX
$16.8B
| $39.6M | 0.03% |
1,023,442
+147,393
| +17% | +$6.67M |
|
515
Consolidated Edison
ED
$40.1B
| $39.5M | 0.03% |
535,467
-23,511
| -4% | -$1.7M |
|
516
Western Digital
WDC
$188B
| $39.4M | 0.03% |
767,242
+93,946
| +14% | +$4.33M |
|
517
Newmont
NEM
$98.7B
| $39.3M | 0.03% |
1,152,443
+23,171
| +2% | +$792K |
|
518
Thomson Reuters
TRI
$42.8B
| $38.9M | 0.03% |
766,429
-221,701
| -22% | -$10.8M |
|
519
Cimpress
CMPR
$2.39B
| $38.9M | 0.03% |
424,745
-28,088
| -6% | -$2.55M |
|
|
RDS.B
520
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $38.8M | 0.03% |
668,975
+288,535
| +76% | +$15.8M |
|
521
RingCentral
RNG
$4.66B
| $38.5M | 0.03% |
1,869,700
+34,800
| +2% | +$761K |
|
522
PACCAR
PCAR
$69.8B
| $38.5M | 0.03% |
903,998
-53,061
| -6% | -$2.14M |
|
523
Williams Companies
WMB
$87.5B
| $38.4M | 0.03% |
1,234,629
+26,082
| +2% | +$786K |
|
524
HCA Healthcare
HCA
$87.2B
| $38.4M | 0.03% |
518,446
-14,868
| -3% | -$1.11M |
|
525
Monolithic Power Systems
MPWR
$70.1B
| $38.3M | 0.03% |
467,944
+6,419
| +1% | +$515K |
|
Similar funds
AllianceBernstein's Q4 2016 Portfolio in Review
As of Q4 2016, AllianceBernstein held 3,102 positions worth $120B, up 1.3% from $118B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AllianceBernstein's Q4 2016 filing shows 125 new, 894 increased, 1,362 reduced and 90 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M. The largest sale was L3 Technologies, Inc., an estimated $529M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- AllianceBernstein's largest Q4 2016 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M.
- AllianceBernstein added most to Edwards Lifesciences in Q4 2016, an estimated $376M increase.
- AllianceBernstein's biggest Q4 2016 reduction was L3 Technologies, Inc., cutting an estimated $529M.
- AllianceBernstein fully exited Amsurg Corp in Q4 2016, selling an estimated $89.6M.
- AllianceBernstein's ten largest holdings make up 14% of its $120B portfolio in Q4 2016.
- AllianceBernstein opened 125 new positions and closed 90 in Q4 2016.
- AllianceBernstein's portfolio value rose 1.3% quarter-over-quarter to $120B.
Based on AllianceBernstein's 13F filing for Q4 2016, filed 13 Feb 2017.